Global Cholangiocarcinoma Therapeutics Market 2019-2023
Published: Feb 2019 | Pages: 120 | SKU: IRTNTR30865 |
Industry Insights
The global cholangiocarcinoma therapeutics market size will grow by USD 82.56 million during 2019-2023 at a CAGR of almost 6%. The growing usage of combination therapy and the need for drugs with minimal side-effects are some of the factors expected to drive market growth. This market report provides a detailed analysis of the market by type (intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Pfizer Inc., and Sanofi.
Cholangiocarcinoma is a rare and highly fatal cancer that starts in the cells of the bile duct. The disease is known to be caused by mutations in various types of genes. It is more common in people above 50 years of age.
Key Insights from Cholangiocarcinoma Therapeutics Market – Global Forecast 2019-2023
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this Cholangiocarcinoma Therapeutics Market report
The lack of effective therapeutics to control the last stages of diseases is compelling surgeons to choose surgery as a treatment option. However, vendors are coming up with a combination of chemotherapies to treat the disease. The growing usage of combination therapy is one of the critical factors that will drive the cholangiocarcinoma therapeutics market. This combination of drugs binds the strands of the cell’s deoxyribonucleic acid to abort the multiplication of cancer cells and hinders the production of both DNA and RNA to prevent cancer cells from repairing themselves.
Even though these chemotherapy drugs are serving the market, the side effects associated with these drugs are many and often severe. This substantial unmet need for drugs with minimal side-effects is encouraging vendors to support the development of novel therapies through massive investments in research activities. This will drive cholangiocarcinoma therapeutics market growth at a CAGR of almost 6% during the forecast period. Most of the novel therapy drugs such as biologics with the mechanism of actions such as PD-1 inhibitors and FGFR inhibitors have shown positive results in treating cholangiocarcinoma.
Industry Analysis
Quantitative Data
|
Qualitative Data
|
Type Insights
The type segment has been segregated into intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma. The intrahepatic cholangiocarcinoma segment accounted for the highest cholangiocarcinoma therapeutics market share in 2018. During the forecast period, this segment will grow at a faster pace than the overall market. The extrahepatic cholangiocarcinoma segment will grow at a slower pace than the overall market.
The intrahepatic cholangiocarcinoma segment will account for the highest share of the cholangiocarcinoma therapeutics market primarily because of the increasing incidence of the disease at the global level. The presence of various large and mid-sized pharmaceutical vendors with novel therapies in the last stages of clinical trials will also boost the growth of the market during the forecast period.
Regional Insights
North America accounted for the highest market share in 2018. Though the market’s growth in this region will be slower than the growth of the market in other regions, it will account for the largest cholangiocarcinoma therapeutics market share throughout the forecast period. The US is a key market for cholangiocarcinoma therapeutics in this region.
The high sales of approved therapeutics for the treatment of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma is one of the primary reasons for the high growth of the cholangiocarcinoma therapeutics market in this region.
Top Cholangiocarcinoma Therapeutics Companies
The market is fairly concentrated. To help clients improve their position, this cholangiocarcinoma therapeutics market analysis report provides information on the competitive landscape and the products offered by various companies. Moreover, this cholangiocarcinoma therapeutics market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.
The report offers a detailed analysis of leading cholangiocarcinoma therapeutics companies, including:
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Pfizer Inc.
- Sanofi
Segments Covered in the Report
Cholangiocarcinoma therapeutics market by type
- Intrahepatic cholangiocarcinoma
- Extrahepatic cholangiocarcinoma
Cholangiocarcinoma therapeutics market by region
- Asia
- Europe
- North America
- ROW
Key Highlights of the Cholangiocarcinoma Therapeutics Market Forecast Report for the Period 2019-2023
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the cholangiocarcinoma therapeutics market size during the next five years
- Precise estimation of the global cholangiocarcinoma therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the cholangiocarcinoma therapeutics industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
-
Comprehensive details of factors that will challenge the growth of cholangiocarcinoma therapeutics companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Intrahepatic cholangiocarcinoma - Market size and forecast 2018-2023
- Extrahepatic cholangiocarcinoma - Market size and forecast 2018-2023
- Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Pfizer Inc.
- Sanofi
PART 14: APPENDIX
- Research methodology
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis